Details of the Drug

General Information of Drug (ID: DMS026F)

Drug Name

BI-1

Synonyms

BI-1; AC1L2R2F; 145551-68-4; SCHEMBL8964991; CHEMBL209801; 1-(7-(2-Hydroxyethyl)dodecahydro-3a-methyl-1H-benz(e)inden-3-yl)ethanone; 3S-(3alpha,3aalpha,5abeta,7alpha,9aalpha,9bbeta)-1-(7-(2-Hydroxyethyl)dodecahydro-3a-methyl-1H-benz(e)inden-3-yl)ethanone; 1-[(3S,3aS,5aR,7R,9aR,9bS)-7-(2-hydroxyethyl)-3a-methyl-1,2,3,4,5,5a,6,7,8,9,9a,9b-dodecahydrocyclopenta[a]naphthalen-3-yl]ethanone; Ethanone, 1-(dodecahyro-7-(2-hydroxyethyl)-3a-methyl-1H-benz(e)inden-3-yl)-, (3S-(3alpha,3aalpha,5abeta,7alpha,9aalpha,9bbeta))-

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H30O2
Canonical SMILES: CC(=O)C1CCC2C1(CCC3C2CCC(C3)CCO)C
InChI: 1S/C18H30O2/c1-12(20)16-5-6-17-15-4-3-13(8-10-19)11-14(15)7-9-18(16,17)2/h13-17,19H,3-11H2,1-2H3/t13-,14+,15+,16+,17-,18+/m0/s1
InChIKey: OOTXTVKIKCULJJ-UIGZQWRCSA-N

Cross-matching ID

PubChem CID: 126873
CAS Number: 145551-68-4
TTD ID: D06LQY

References

1	Clinical pipeline report, company report or official report of Morphosys.